Taysha Gene Therapies, Inc. TSHA Payment for (Proceeds from) Other Investing Activity
Payment for (Proceeds from) Other Investing Activity at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.
The official record: Taysha Gene Therapies, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s payment for (proceeds from) other investing activity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s payment for (proceeds from) other investing activity?
- Taysha Gene Therapies, Inc. (TSHA) reported payment for (proceeds from) other investing activity of -$3K in Q4 2025.
- How has Taysha Gene Therapies, Inc.'s payment for (proceeds from) other investing activity changed year-over-year?
- Taysha Gene Therapies, Inc.'s payment for (proceeds from) other investing activity decreased by 9.1% year-over-year, from -$2.75K to -$3K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s payment for (proceeds from) other investing activity?
- Over 2 years (2022 to 2025), Taysha Gene Therapies, Inc.'s payment for (proceeds from) other investing activity has grown at a 48.2% compound annual growth rate (CAGR), from $61K to -$134K.
- What does payment for (proceeds from) other investing activity mean?
- Net cash flows resulting from investing activities that do not fall under standard categories like securities or loans. This may include investments in joint ventures, real estate, or other non-financial assets. It serves as a catch-all for miscellaneous capital deployment or divestment activities.